Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Seidal

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Cancer|November 7, 2013
Napsin A as a marker of clear cell ovarian carcinomaIngiridur Skirnisdottir, Kathrine Bjersand, Helena Akerud, et al.
International Journal of Oncology|December 9, 2004
Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-IIIngirídur Skírnisdóttir, Tomas Seidal, Mats G Karlsson, et al.
EJNMMI Research|January 5, 2012
Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted miceAnn Erlandsson, Eva Forssell-Aronsson, Tomas Seidal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancerIngirídur Anna Skírnisdóttir, Bengt Sorbe, Katarina Lindborg, et al.
Cancer Genomics & Proteomics|October 30, 2019
Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-IIIngiridur Skirnisdottir, Helena Akerud, Tomas Seidal, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 8, 2015
Macrophages of M1 phenotype have properties that influence lung cancer cell progressionAlexander Hedbrant, Jonny Wijkander, Tomas Seidal, et al.
BMC Urology|December 7, 2010
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomyDragomir P Zubac, Tore Wentzel-Larsen, Tomas Seidal, et al.
Plos One|June 14, 2017
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancerKathrine Bjersand, Tomas Seidal, Inger Sundström-Poromaa, et al.
Croatian Medical Journal|April 30, 2005
Nordic immunohistochemical quality controlMogens Vyberg, Emina Torlakovic, Tomas Seidal, et al.
BMC Urology|December 23, 2008
The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomyDragomir P Zubac, Leif Bostad, Tomas Seidal, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Cancer|November 7, 2013
Napsin A as a marker of clear cell ovarian carcinomaIngiridur Skirnisdottir, Kathrine Bjersand, Helena Akerud, et al.
International Journal of Oncology|December 9, 2004
Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-IIIngirídur Skírnisdóttir, Tomas Seidal, Mats G Karlsson, et al.
EJNMMI Research|January 5, 2012
Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted miceAnn Erlandsson, Eva Forssell-Aronsson, Tomas Seidal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancerIngirídur Anna Skírnisdóttir, Bengt Sorbe, Katarina Lindborg, et al.
Cancer Genomics & Proteomics|October 30, 2019
Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-IIIngiridur Skirnisdottir, Helena Akerud, Tomas Seidal, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 8, 2015
Macrophages of M1 phenotype have properties that influence lung cancer cell progressionAlexander Hedbrant, Jonny Wijkander, Tomas Seidal, et al.
BMC Urology|December 7, 2010
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomyDragomir P Zubac, Tore Wentzel-Larsen, Tomas Seidal, et al.
Plos One|June 14, 2017
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancerKathrine Bjersand, Tomas Seidal, Inger Sundström-Poromaa, et al.
Croatian Medical Journal|April 30, 2005
Nordic immunohistochemical quality controlMogens Vyberg, Emina Torlakovic, Tomas Seidal, et al.
BMC Urology|December 23, 2008
The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomyDragomir P Zubac, Leif Bostad, Tomas Seidal, et al.
Pageof 4